NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $160.38 +2.42 (+1.53%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends About VanEck Biotech ETF (NASDAQ:BBH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VanEck Biotech ETF alerts:Sign Up Key Stats Today's Range$158.01▼$160.3850-Day Range$157.62▼$181.8252-Week Range$148.52▼$183.64Volume5,293 shsAverage Volume6,674 shsMarket Capitalization$404.15 millionAssets Under Management$398.43 millionDividend Yield0.44%Net Expense Ratio0.35%Aggregate RatingModerate Buy ETF OverviewThe BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More… New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.57%0.55%0.49%0.52%Other Expenses0.00%0.30%0.49%0.41%0.53%Total Expense0.35%0.70%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.52%-0.32%-0.57%Net Expense0.35%0.61%0.61%0.56%0.59% Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBH ETF News HeadlinesAre Rate Cuts Bad News For BIZD ETF?September 10, 2024 | seekingalpha.comEmphasize Consistency To Navigate VolatilitySeptember 7, 2024 | seekingalpha.comJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.November 21, 2024 | Priority Gold (Ad)VanEck Fabless Semiconductor ETF (NASDAQ:SMHX) Quotes, Forecast and News SummaryAugust 29, 2024 | benzinga.com3 Biotech ETFs for a Diversified PortfolioAugust 15, 2024 | stocknews.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 29, 2024 | benzinga.comSee More Headlines BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $165.31 on January 1st, 2024. Since then, BBH stock has decreased by 3.0% and is now trading at $160.3775. View the best growth stocks for 2024 here. Who are VanEck Biotech ETF's major shareholders? Top institutional shareholders of VanEck Biotech ETF include International Assets Investment Management LLC (44.76%), Miller Investment Management LP (3.96%), HighTower Advisors LLC (0.35%) and Jane Street Group LLC (0.33%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ). Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$398.43 million Average Daily Volume$5,312.10 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume2 Put Options1 Call Options1 Short Interest600 shs Miscellaneous Outstanding Shares2,520,000Beta0.74 Creation Unit50,000 Creation Fee$500.00 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Top 10 BBH HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 16.54%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 11.11%Gilead Sciences (NASDAQ:GILD)Holding Weight: 10.83%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 6.85%argenx (NASDAQ:ARGX)Holding Weight: 5.41%IQVIA (NYSE:IQV)Holding Weight: 4.64%Illumina (NASDAQ:ILMN)Holding Weight: 4.30%Biogen (NASDAQ:BIIB)Holding Weight: 3.88%Natera (NASDAQ:NTRA)Holding Weight: 3.59%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.46%Full Holdings DetailsBBH Sector ExposureBBH Industry Exposure This page (NASDAQ:BBH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
